HIV can end now: Groundbreaking drug to be rolled out from 2027 at an affordable price (know how much it will cost)
A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per year, this long-acting medication has demonstrated over 99.9% effectiveness in preventing HIV transmission.
A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per year, this long-acting medication has demonstrated over 99.9% effectiveness in preventing HIV transmission.
